Clearmind Medicine (CSE: CMND), a psychedelic medicine biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and undertreated health problems, is working with Yissum Research Development Company, the technology transfer company of The Hebrew University of Jerusalem. The two entities are partnering on a research and development project focused … Continue reading InvestorNewsBreaks – Clearmind Medicine Inc. (CSE: CMND), The Hebrew University Partner to Focus on Development of Novel Psychedelic Drug